These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2250909)

  • 1. Identification of a PDGF-responsive element in the murine c-myc gene.
    Sacca R; Cochran BH
    Oncogene; 1990 Oct; 5(10):1499-505. PubMed ID: 2250909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labile repressors are involved in the transcriptional control of PDGF-responsive genes.
    Hall DJ; Alberta JA; Stiles CD
    Oncogene Res; 1989; 4(3):177-84. PubMed ID: 2544848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-sis/platelet-derived growth factor-B promoter requirements for induction during the 12-O-tetradecanoylphorbol-13-acetate-mediated megakaryoblastic differentiation of K562 human erythroleukemia cells.
    Kujoth GC; Fahl WE
    Cell Growth Differ; 1997 Sep; 8(9):963-77. PubMed ID: 9300179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters.
    Gutsch DE; Marcu KB; Kenney SC
    Cell Mol Biol (Noisy-le-grand); 1994 Sep; 40(6):747-60. PubMed ID: 7812182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element.
    Berberich SJ; Postel EH
    Oncogene; 1995 Jun; 10(12):2343-7. PubMed ID: 7784082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cis-platin responsive sequences in the human c-myc promoter.
    Spandidos DA; Zoumpourlis V; Lang JC
    Anticancer Res; 1991; 11(3):1339-42. PubMed ID: 1888169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
    Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
    Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the c-myc P2 promoter.
    Moberg KH; Tyndall WA; Pyrc J; Hall DJ
    J Cell Physiol; 1991 Jul; 148(1):75-84. PubMed ID: 1860897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle dependent growth factor regulation of gene expression.
    Morgan CJ; Pledger WJ
    J Cell Physiol; 1989 Dec; 141(3):535-42. PubMed ID: 2512304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of IL-3 on promoter usage, attenuation and antisense transcription of the c-myc oncogene in the IL-3-dependent Ba/F3 early pre-B cell line.
    Chang Y; Spicer DB; Sonenshein GE
    Oncogene; 1991 Nov; 6(11):1979-82. PubMed ID: 1682864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acidic fibroblast growth factor gene 5' non-coding exon and flanking region from hamster DDT1 cells: identification of the promoter region and transcriptional regulation by testosterone and aFGF protein.
    Hall JA; Harris MA; Intres R; Harris SE
    J Cell Biochem; 1993 Jan; 51(1):116-27. PubMed ID: 7679390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo.
    Lavenu A; Pournin S; Babinet C; Morello D
    Oncogene; 1994 Feb; 9(2):527-36. PubMed ID: 8290263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription from the P2 promoter of human protooncogene myc is suppressed by retinoic acid through an interaction between the E2F element and its binding proteins.
    Ishida S; Shudo K; Takada S; Koike K
    Cell Growth Differ; 1994 Mar; 5(3):287-94. PubMed ID: 8018561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Position and orientation independent transactivation by c-Myc.
    Packham G; Bello-Fernandez C; Cleveland JL
    Cell Mol Biol Res; 1994; 40(7-8):699-706. PubMed ID: 7787888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription activation by serum, PDGF, and TPA through the c-fos DSE: cell type specific requirements for induction.
    Siegfried Z; Ziff EB
    Oncogene; 1989 Jan; 4(1):3-11. PubMed ID: 2915902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of doxorubicin, daunorubicin and 4'-epidoxorubicin on the exogenous c-myc promoter in mouse erythroleukemia cells.
    Eliopoulos A; Kerr DJ; Spandidos DA
    Anticancer Res; 1991; 11(6):2153-7. PubMed ID: 1776855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of c-myc regulation by c-Myb in different cell lineages.
    Cogswell JP; Cogswell PC; Kuehl WM; Cuddihy AM; Bender TM; Engelke U; Marcu KB; Ting JP
    Mol Cell Biol; 1993 May; 13(5):2858-69. PubMed ID: 8474446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation.
    Pietenpol JA; Holt JT; Stein RW; Moses HL
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3758-62. PubMed ID: 2187192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.